Member Info for Forrestdreams

hanker after a Friday afternoon rns like the Medimmune one back in February. What a n afternoon that was. Think we closed at pretty much where the SP is today, and that was a huge afternoon. Bodes well for reaching new highs this year when further news arrives,,,

Agree AJ - market cap supressed again recently so good, potentially multiple, news items could have quite a dramatic effect on the SP.

Also bought another 100K today :))

News could be inbound given timescale since visit and subsequent discussions... just a hunch...

Backed by big trades. Something is afoot that�s for sure. Looking forward to tomorrow!

Had to happen - lets see what juicy news the next few days bring...

there's big sell. Had to be given the buying pressure of the last hour or two.

Just had a lovely wee top up :))

small �1K top up - trying to pus my holding up as we await, what I think will be a raft of Nuvec news in the near term, and also positive Sildenafil results. The human trials are pretty low risk of being unsuccessful, given we know Viagra already works, and N4 have adjusted the form of the tablet (coating etc), simply to make it more effective - and it's shown in, in vitro studies to work.... ATB All.

Not much to say at this stage except, I'm waiting with excitement and managing the odd meagre top up below 20. Still here for all the thrills to come and hope everyone is well!

Wouldn't grumble with a move to 4p if we then get news to keep the momentum going...

a joke relative to peers and given revenues. Investors could simply be positioning themselves for the rerate to come...which will boost the SP...

If you were Pfizer, why wouldn't you be eyeballing N4P? What an exciting couple of months head into Sildenafil results. ATB All.

Looking forward to it as well Leister. Shouldn't contain a lot we don't already know, however, always good to see the evolving details as we progress....

From the AGM presentation, it was Helios-Hybrid that is noted as awaiting the final stage of tender process from a global organisation. ATB

Hence the recent appointment of the new marketing and sales director... :))

of company, we should be trading above the previous high of ~80p. Looks like a move is afoot, if the selling could just dry up for a bit...

N4P appearing at Mello UK investor show today/tomorrow - may rally some interest as per the investor presentation in November last year.

trading below 3.5 this week given solid indication of Bosch tie in.

seems to be in stable range for now at between 20-25p which is excellent but still undervalued IMO. 'Near term' is the phrase used by Nigel re commercialisation of Nuvec, so I would tend to think that the company will avoid further dilution if possible. That said, could be that they decide to move ahead with other drugs in the reformulation pipeline and raise some funds. With low number of shares in issue, adding e.g. 10% wouldn't be an issue IMO, however, I doubt that will be the preferred route of the BOD. Could we begin to see a strategic partnership with another pharma being formed...?